001     136016
005     20240321220011.0
024 7 _ |a pmid:19767654
|2 pmid
024 7 _ |a 1467-3037
|2 ISSN
024 7 _ |a 1467-3045
|2 ISSN
037 _ _ |a DZNE-2020-02338
041 _ _ |a English
082 _ _ |a 570
100 1 _ |a Miesbauer, Margit
|0 P:(DE-2719)9000214
|b 0
|e First author
245 _ _ |a Targeting of the prion protein to the cytosol: mechanisms and consequences.
260 _ _ |a Wymondham, Norfolk
|c 2010
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1709562736_22645
|2 PUB:(DE-HGF)
|x Review Article
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a Prion diseases are characterized by the conformational transition of the cellular prion protein (PrP(C)) into an aberrant protein conformer, designated scrapie-prion protein (PrP(Sc)). A causal link between protein misfolding and neurodegeneration has been established for a variety of neurodegenerative disease, such as Alzheimer's disease, Parkinson's disease and polyglutamine diseases, but there is an ongoing debate about the nature of the neurotoxic species and how non-native conformers can damage neuronal populations. PrP is normally imported into the endoplasmic reticulum (ER) and targeted to the outer leaflet of the plasma membrane via a glycosylphosphatidylinositol (GPI) anchor. However, several conditions, such as ER stress or some pathogenic mutations in the PrP gene, can induce the mislocalization of PrP in the cytosol, where it has a neurotoxic potential as demonstrated in cell culture and transgenic mouse models. In this review we focus on intrinsic factors and cellular pathways implicated in the import of PrP into the ER and its mistargeting to the cytosol. The findings summarized here not only reveal a complex regulation of the biogenesis of PrP, but also provide interesting new insight into toxic activities of pathogenic protein conformers and quality control pathways of ER-targeted proteins.
536 _ _ |a 342 - Disease Mechanisms and Model Systems (POF3-342)
|0 G:(DE-HGF)POF3-342
|c POF3-342
|f POF III
|x 0
588 _ _ |a Dataset connected to PubMed,
650 _ 7 |a Glycosylphosphatidylinositols
|2 NLM Chemicals
650 _ 7 |a Prions
|2 NLM Chemicals
650 _ 2 |a Animals
|2 MeSH
650 _ 2 |a Cytosol: metabolism
|2 MeSH
650 _ 2 |a Endoplasmic Reticulum: metabolism
|2 MeSH
650 _ 2 |a Glycosylphosphatidylinositols: metabolism
|2 MeSH
650 _ 2 |a Humans
|2 MeSH
650 _ 2 |a Models, Biological
|2 MeSH
650 _ 2 |a Prion Diseases: genetics
|2 MeSH
650 _ 2 |a Prion Diseases: metabolism
|2 MeSH
650 _ 2 |a Prions: genetics
|2 MeSH
650 _ 2 |a Prions: metabolism
|2 MeSH
650 _ 2 |a Protein Transport: genetics
|2 MeSH
650 _ 2 |a Protein Transport: physiology
|2 MeSH
700 1 _ |a Rambold, Angelika S
|0 P:(DE-HGF)0
|b 1
700 1 _ |a Winklhofer, Konstanze F
|0 P:(DE-HGF)0
|b 2
700 1 _ |a Tatzelt, Jörg
|0 P:(DE-HGF)0
|b 3
773 _ _ |g Vol. 12, no. 2
|0 PERI:(DE-600)2090836-2
|n 2
|q 12:2
|p 10.21775/cimb.012.109
|t Current issues in molecular biology
|v 12
|y 2010
|x 1467-3037
856 4 _ |u https://www.mdpi.com/1467-3045/12/2/00109
856 4 _ |u https://pub.dzne.de/record/136016/files/DZNE-2020-02338.pdf
856 4 _ |u https://pub.dzne.de/record/136016/files/DZNE-2020-02338.pdf?subformat=pdfa
|x pdfa
909 C O |p VDB
|o oai:pub.dzne.de:136016
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 0
|6 P:(DE-2719)9000214
913 1 _ |a DE-HGF
|b Gesundheit
|l Erkrankungen des Nervensystems
|1 G:(DE-HGF)POF3-340
|0 G:(DE-HGF)POF3-342
|3 G:(DE-HGF)POF3
|2 G:(DE-HGF)POF3-300
|4 G:(DE-HGF)POF
|v Disease Mechanisms and Model Systems
|x 0
914 1 _ |y 2010
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b CURR ISSUES MOL BIOL : 2017
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0310
|2 StatID
|b NCBI Molecular Biology Database
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
915 _ _ |a WoS
|0 StatID:(DE-HGF)0111
|2 StatID
|b Science Citation Index Expanded
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1120
|2 StatID
|b BIOSIS Reviews Reports And Meetings
915 _ _ |a IF < 5
|0 StatID:(DE-HGF)9900
|2 StatID
920 1 _ |0 I:(DE-2719)5000053
|k Ext AG Tatzelt
|l Ext Neurobiochemistry, LMU
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-2719)5000053
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21